Home / Transcripts / Research Solutions, Inc. (RSSS) · February 12, 2026

Research Solutions, Inc. (RSSS) Earnings Call Transcript

February 12, 2026

NASDAQ US Information Technology IT Services earnings 50 min

Earnings Call Speaker Segments

John Beisler executive
#1

Thanks, operator. Hello everybody, and we appreciate you being here for the Research Solutions call covering our second quarter of fiscal year 2026 results. Joining me are President and Chief Executive Officer Roy W. Olivier, Chief Financial Officer Dave Kutil, and Chief Strategy Officer Josh Nicholson. The company put out a press release this afternoon once the market had closed, sharing its fiscal 2026 second quarter results. You can find that release on researchsolutions.com, the company's website. Prior to Roy, Dave and Josh delivering their prepared comments, I want to note that certain statements shared today are forward-looking and are being made under the Private Securities Litigation Reform Act of 1995. The outcomes we ultimately report could end up being quite different from what's been stated or suggested here, and that's because many different elements can influence things. For a closer look at the dangers and unknowns that might affect how Research Solutions performs operationally and financially going forward, we point you toward the company's latest documents filed with the SEC. In addition, during this call, members of management will bring up some non-GAAP financial metrics, and our view is that these give investors helpful information. Today's earnings press release also contains a reconciliation showing how those metrics line up with GAAP figures. Last of all, I want to let everybody know that a recording is being made of this call, and it can be accessed for replay through a link posted on the company's website. At this point, I'll hand things over to Roy W. Olivier, our President and CEO. Roy, go ahead.

Roy Olivier executive
#2

Thanks, John. When it comes to our results, fiscal Q2 was something of a mixed picture. We saw a year-over-year drop in transactions, and that was mostly driven by a single known account that churned plus a handful of bigger customers whose volumes fell considerably. If you set those accounts aside, we were down roughly 2%, which falls within what we view as typical for this business, shaped by our corporate research intensity and academic budgets. That decrease should persist through the back half of the year. In this segment we do have certain levers available that we believe can lift the results, and we're putting hard work into those initiatives; beyond that, competition keeps intensifying in the B2C segment, as our Q2 results show, and we anticipate that headwind through the second half of the year. Let me also point out that we concentrate on annual or multiyear agreements in B2B, whereas the B2C business is mainly a month-to-month subscriber-based operation; moving forward, B2B annual and multiyear agreements will remain our primary growth driver and our focus. With all of that in mind, we're improving both product and sales processes to raise our conversion rate in this business neatly. We're delivering improvements — software as well as new data, such as adding patent data — at a faster pace than ever before. We'll keep innovating, refining our sales process, and investing in marketing so results in this area get better. Josh will cover a number of those product improvements afterward on this call. Our B2B segment delivered strong results in ARR bookings and net ARR bookings alike. The 47 net new deployments in B2B highlight that customers are enthusiastic about what we offer now and what we'll develop in the future. These results show a better product being sold by a disciplined, focused sales team. We achieved good results across our corporate, academic, and upsell teams; at the pipeline stage, year-over-year ASP growth remains very strong; and as our earnings release noted, ASP rose 6% during the quarter. To be clear, I'm very pleased with how we performed on operating and net income, EBITDA and cash flow; there is still work ahead of us on the overall SaaS growth rate, and we'll work hard to bring that rate back to 20-plus percent. I'd like to hand the call to Dave so he can walk you through the fiscal quarter and full year 2025 — I'm sorry, the fiscal quarter and FY '26 year-to-date financial results in detail, and after that I'll close with some comments and the outlook for 2026. Dave?

Dave Kutil executive
#3

Thanks, Roy. Good afternoon, everybody. For the second quarter of fiscal 2026, total revenue came in at $11.8 million, versus $11.9 million during the same quarter in fiscal 2025. Platform subscription revenue rose by about 14%, reaching $5.2 million. That growth came mainly from a net gain of 47 platform deployments over the prior year, along with expansion inside our current customer base via upsells and cross-sells; we closed the quarter with $21.8 million in annual recurring revenue, or ARR, which is up 14% year-over-year, made up of roughly $15.3 million in B2B ARR and approximately $6.4 million in normalized ARR tied to sites B2C subscribers. Incremental ARR totaled $560,000 for the quarter — the strongest organic second quarter in the company's history. Although we saw softness in B2C ARR, that was mainly the result of a deliberate pullback in certain marketing channels where trial to subscriber conversion had been lagging. We're putting cohort quality and retention ahead of short-term B2C growth, which we think sets up this part of the business for a more durable and profitable contribution over time. For details on how we define and use annual recurring revenue and other non-GAAP items, please see today's press release. Transaction revenue for the second quarter was $6.6 million, compared with $7.3 million in the prior year quarter. That softness in transaction revenue stemmed largely from a previously discussed churned account and volume reductions from a small number of larger customers. Our total active customer count for the quarter was 1,321, versus 1,384 in the same period a year ago. Gross profit for the first quarter was $6.2 million, up 6% from the prior year quarter. Gross margin was 52.4%, which constitutes a 350 basis point improvement over the second quarter of 2025. That increase reflects the ongoing revenue mix shift towards our higher-margin platforms business, which was also enhanced by expanding gross margins in the Platforms business. Platform revenue made up 44% of revenue in the quarter, compared with 39% in the prior year quarter; on a trailing 12-month basis, the company's blended gross margin now stands at 50.8%. The Platform business recorded a gross margin of 88.1%, a 160 basis point increase compared to the prior year. We've been able to keep expanding gross margins in the platform business as our labor and hosting costs continue to increase at a proportionately slower pace than our revenues. Gross margin in our transaction business was 24%, compared with 25.2% in the prior year quarter. That decrease was primarily attributable to lower fixed cost leverage due to the reduced revenue base and some pressure on copyright-related margins. Total operating expenses in the quarter were $5.4 million, compared with $5.7 million in the prior year quarter. Lower general and administrative expenses and lower stock-based compensation more than offset an increase in sales and marketing investments. We've stayed quite deliberate about holding the line on general and administrative expenses even while steering more resources toward growth efforts, and we anticipate continuing to produce operating leverage as the business expands. For the quarter, net income came in at $547,000, which works out to $0.02 per diluted share, versus a net loss of $2 million, or $0.07 per share, in the same quarter last year. The earlier quarter's figures contained a charge of roughly $2.4 million tied to the anticipated contingent earn-out liability for site. Adjusted EBITDA for the quarter reached $1.3 million, up against $963,000 in the comparable quarter a year ago — a 36% gain. Measured over a trailing 12-month period, our adjusted EBITDA margin stood at 11.8%, which is a 230 basis point improvement from the close of calendar 2024. I'd also note that, looking at history, Q3 and Q4 tend to be our best quarters where adjusted EBITDA is concerned. Now to the balance sheet. Cash and cash equivalents on December 31, 2025, totaled $12.3 million, compared with $12.2 million as of June 30, 2025; that figure reflects 2 payments tied to the site earnout, amounting to a combined $2.6 million in cash plus the issuance of roughly 487,000 shares of stock. Cash flow from operations was $1.4 million, which is a 35% rise from $1 million during the second quarter of fiscal '25, and it mirrors both stronger profitability and careful working capital management. Our view remains that we can build up our cash balance during fiscal '26 while covering the remaining site earn-out obligations wholly out of operating cash flow. We likewise closed the quarter owing nothing on our revolving line of credit, which gives us added flexibility on the balance sheet. As we head into the back half of our fiscal year, which is traditionally stronger, we feel our balance sheet is nicely positioned to seize high-return growth opportunities via a strategic approach. Reflecting on the fiscal year's first half, we posted a substantial year-over-year gain in net deployments, cash from operations and EBITDA. Despite top line pressure in B2C and transactions, we lifted gross profit and enhanced our overall profitability profile, which shows the operating leverage built into our business model as we scale platform ARR. For the year's back half, our aim is still to surpass fiscal 2025 EBITDA levels in each remaining quarter and to generate additional growth in the cash flows the business produces. We expect ongoing platform subscription growth, a steadier trajectory in transactions and sustained rigor around operating expenses to support this, even as we make targeted investments in sales, marketing and product. All told, we believe we're positioned to finish the fiscal year with a stronger run rate for earnings and cash generation, while keeping balance sheet flexibility to fund disciplined high-return growth initiatives. I'll now hand the call back to Roy. Roy?

Roy Olivier executive
#4

Appreciate that, Dave. I want to point out to our investors that our performance in the back half of the year has generally been stronger than what we delivered in the first six months. That pattern should hold true going forward when it comes to B2B and transactions. A key driver behind the robust B2B expansion we've recorded relates to our product roadmap and direction. Our conviction is that we're headed the right way, and the fact that customers are putting their money behind us validates that conviction. I imagine everyone has noticed how the market has reacted to AI news during the last 10 days, and just like many other companies, that reaction hit our share price; there's clearly a sell-first mindset when it comes to AI headlines; from where we stand, enterprise software whose purpose is speeding up work does confront a certain degree of disruption. Our position remains that the distinctive things we can do and the data we hold aren't vulnerable to those tools or to LLMs broadly. Because we're able to search behind paywalls, we deliver fewer hallucinations and stronger search results; on top of that, we provide rights management, covering which rights apply to articles you've bought — items such as AI rights, reprint rights, and so on; we handle the entitlements belonging to a company or a library, meaning which articles get purchased individually, which ones are subscribed to, which ones fall under discount packages, and what's already available in their collection; and we provide distinctive tools that let researchers gauge the quality and efficiency of the articles they're reviewing. We're still building out a complete workflow tool comparable to the Bloomberg terminal, except aimed at researchers, yet at the same time our focus is on delivering that distinctive capability inside whatever workflow the customer already uses; in some cases that means their own tools. Looking ahead, we'll back companies that adopt an LLM as their standard. That's functioning today. I'm able to pose a research-oriented question through Claude or ChatGPT, and Claude will leverage our site connector to produce an answer with full citations drawn exclusively from peer-reviewed articles, drawing on our distinctive data, our citation graph, and our rights management data. After that, the user can instruct Claude to engage our products right there in the tool so those cited articles come through, and we'll integrate with the rights management, the company library, and their entitlements to supply those articles; we're even able to report which rights they hold for those items, which in many instances assists them in securing the rights needed to accomplish what they're after. Take a situation where someone wants to summarize a number of AI articles to get ready for a meeting; we're able to assist them in doing so in a way that complies with copyright. Josh is going to cover our new products in a moment. Actually, let me hand the call to Josh so he can discuss our thinking on product strategy and usage. Josh?

Josh Nicholson executive
#5

Absolutely, Roy, and good morning, everyone. What I'd like to cover today are two foundational changes underway in our operations—changes that aren't merely about getting better at what we do, but rather a reinvention of the way research solutions generates value. At the heart of these changes is our pivot toward API and AI integration, alongside our progression from a company that delivers documents into what I refer to as an Answers and access platform. These changes have been in motion for some time, I've touched on them during earlier calls, and in my view they set us up nicely amid all the macro developments surrounding AI. I'll address two items: first, API and AI integration sales turning into infrastructure, and then a separate theme afterward. The most significant evolution in our operations involves the manner in which clients purchase from us—both newly acquired clients and a great many of our long-standing ones. Rather than simply buying seats so researchers can sign in to our platforms, clients are now embedding our offerings straight into their own systems and AI tools. Selling seats to a platform is no longer all we do. What we're selling is infrastructure. A top pharmaceutical company has no interest in making their researchers bounce among 10 separate tools. What they want is citation verification plus Article Galaxy rights cleared content reachable from wherever their researchers happen to be working, be that an in-house AI system or a proprietary drug discovery platform; this is what we term API sales, and it's fueling several of the biggest contracts we've ever signed; such deals generally run 2x to 5x the size of conventional seat-based sales, and they stick around longer. Once we're woven into a client's core infrastructure, we turn into something mission-critical rather than merely another subscription they could drop. Here's the reason this matters. Any company creating AI tools for research runs into identical obstacles; they require accurate citations, copyright compliance and access to scientific articles. Rather than having every company tackle these issues on its own with thousands of publishers, we build the solution a single time and extend it to all of them via straightforward integration. This capitalizes on and repositions our publisher partnerships, some of which required over a decade to establish. Today we deliver access to more than a dozen specialized research data sets covering various disciplines and geographies, ranging from life sciences to physical sciences, from research articles to patents and to clinical trials and beyond. When an AI platform connects with us, what they receive isn't access to a single database—they receive comprehensive coverage of global research. That scope is precisely what renders us valuable infrastructure. We're already witnessing robust momentum with this strategy. A number of enterprises have started leveraging our technology to drive their internal AI research assistance. Though it's still early days, publishers are likewise engaged in conversations with us about tapping our infrastructure to provide their subscriptions with AI access to their own customers, without needing to construct the copyright and citation systems on their own. The key takeaway: we're transitioning away from selling seat-based software subscriptions and toward selling infrastructure. Infrastructure businesses enjoy superior economics, bigger contract values, reduced churn and greater expansion opportunities. A major pharmaceutical firm already places more than 1 million calls annually to our API. The second phase I'd like to address concerns going from documents to what I refer to as Answers and Access. That leads me to the broader picture here. Research Solutions is transitioning away from being a document delivery operation toward an Answers and Access platform. Under the previous approach, things were simple. Articles are what researchers require, so articles get delivered, and the transaction ends there. With the new approach, it works differently. Rather than beginning with a thought like "I need this particular article," researchers begin with questions. I have to grasp how this mechanism works. I have to confirm whether this hypothesis holds up. I have to find evidence supporting this claim. What they seek first is answers, not documents. Supplying both is our role. Through site, we supply answers, assisting them in locating pertinent citations, checking claims, and comprehending what the research indicates. Whenever they must dig further, we supply access via Article Galaxy, providing complete articles along with correct copyright clearance. Answers and Access — that's the meaning behind that phrase. Document delivery isn't being dropped; instead we're integrating it into a fuller solution whose starting point is responding to research questions. The market is confirming this strategy. Clients that previously relied on us solely for article fulfillment now roll out site throughout their whole organization for literature review and research validation. Academic institutions are widening their use from individual researcher access toward broader applications, and publishers that once viewed us merely as a fulfillment vendor now inquire how we might assist them in generating new revenue from AI usage of their content. Here's the reason this is significant. These two ships — API integration sales along with Answers and Access — operate jointly and strengthen one another. Thanks to our API strategy, embedding our services wherever researchers require answers becomes simple, and because of our Answers and Access model, we function not as a commodity service but as mission-critical infrastructure supporting research decisions. That's why we're developing integrations and developer tools, among them a new API for Article Galaxy, which was deployed recently; that's why we hold the belief that research solutions' long-term value stems from serving as the infrastructure that renders AI trustworthy for scientific research. We're no longer merely in the document delivery business; we're in the research intelligence business. In a world where AI is turning into the main channel through which people obtain information, the victors will be those companies supplying verified, compliant, citation-backed infrastructure that researchers and companies are able to trust. That's the future we're building for research solutions to move toward, and it excites us. Thank you, and I'll now hand it back to Roy.

Roy Olivier executive
#6

Appreciate it, Josh. A post went up on X not long ago discussing how there are two categories of software companies. Type 1 covers software that people click on — dashboards, CRMs, project management, various other tools, essentially offerings giving a human interface for completing a task. If automation of a task is all you provide, AI poses a danger. Type 2 covers software bots. That takes in APIs, databases, authentication, infrastructure, and more. Such functions are distinctive, like curated data, data behind paywalls, customer entitlement information, customer library information, rights information, and so on. They carry unique capability and usually involve tolls or charges tied to usage. Our company began with unique access to the world's peer-reviewed scientific content; we continue to hold unique capability in this area today in numerous ways, among them the ability to help customers locate obscure or hard to obtain content. We later added entitlement capability, rights information, the ability to store a corporate library, et cetera. From that, we built Article Galaxy so these unique databases, authentication capability, and rights information could serve our customer. What's taking place now is that we're coming full circle by bringing our unique core capabilities to AI and LLMs; we remain confident that we're well-positioned to seize the opportunity of this shift to an AI world. Our strong B2B results give us confidence that we're on the right track. With that, I'd like to hand the call back over to our operator for Q&A. Operator?

Jacob Stephan analyst
#7

To kick things off, the B2B numbers look really strong. Could you say a bit about what's in the pipeline? Perhaps you could compare and contrast whether the bigger deals are tied specifically to that headless API, AI model you've been developing over the past few quarters?

Roy Olivier executive
#8

Sure. Our pipeline has expanded steadily both sequentially and compared with a year ago; and these "API deals" now make up a substantial share of it, where we're embedding ourselves into larger customers' workflows. As a result, those deals are considerably bigger.

Jacob Stephan analyst
#9

And perhaps looking at it through a business-to-consumer lens, clearly you've got those positive student enrollment patterns now swinging your way. Could you share any initial anecdotal observations about how that segment might be getting back to growth during the back half?

Roy Olivier executive
#10

Yeah. We weren't sure whether it would, honestly. That's the reason I deliberately left it out when I mentioned the latter six months of the year, we'll see transactions in the B2B side be more robust than the opening six months. What we're observing right now comes down to a couple of things. First is significantly fiercer digital marketing spending to bring in trial customers. So an individual goes out and does a Google search, they locate us. Well, they also locate every other company that's come into this arena over the past 12 or 24 months, and all of us are bidding on the identical keywords. So it's gotten far more competitive to draw users onto the platform. Even more significantly, we're noticing the rate at which trials convert into users is below what it was 12 months back. Put differently, we still bring in just as many trials as 12 months ago, it's simply that our conversion rate has dropped. And that's precisely where Josh and his group are putting in tremendous effort to layer on items such as patents, patent data alongside the peer-reviewed scientific research data, plus fresh features and capabilities, all aimed at pushing that conversion rate higher. Anything else you'd like to mention, Josh?

Josh Nicholson executive
#11

Yeah, I believe that's accurate. Our attention has consistently been on achieving a steadier, greater per-user foundation within B2B licenses; consequently, many product choices have revolved around that, correct? So what we're observing is this B2C2B sales approach, where frequently somebody comes in, tries it out for 1 month, and afterward presents it to their entire team at the big pharma company. Thus, I believe much of this also involves us driving harder and concentrating more on B2B, since that's where the revenue comes with a larger average expense for each user plus contracts that are more reliable, yearly as the standard instead of monthly, which is what characterizes most B2C.

Dave Kutil executive
#12

Right. And I'd add that during Q2, we actually observed churn come down compared with the same period a year earlier, and that pattern has carried on into Q3. So things are moving the way they should; it's precisely the point Roy made regarding conversion — trials turning into new subscribers — which is truly having an effect on us.

Jacob Stephan analyst
#13

Perhaps just one final question. Dave, by now it appears you've been in the role for a couple of months. Could you maybe share the top 3 items you're kind of examining and aiming to make improvements on?

Dave Kutil executive
#14

Yes. So we are really focusing on the things within our control; so as far as I'm concerned, that means the operating expense rigor I mentioned; we're working through it. There's a cost savings program we have, and under it we're examining every one of our vendors, hunting for redundancies, and genuinely attempting to enhance that, and the results there have us excited. So that's the first thing. Beyond that, we're really getting into the weeds with our sellers, working side by side to truly understand what's driving customer losses in certain areas and making sure we get ahead of it. Working capital is another area we watch closely. It's something firmly within our control. The cash flow we've generated from operations makes us proud — it's what's been covering the site earn-out payments — and we keep steering it while hunting for ways to bring in more cash. To that end, we gather every week to confirm we're hitting our targets and to maintain a projection we can stand behind with our investors.

Richard Baldry analyst
#15

You've covered pretty well how AI is being applied externally in a productized way. I'd also like you to discuss — it appears to me there's substantial opportunity for bringing AI technologies in-house to cut expenses or boost the pace of output, efficiencies, and so on, in fields such as development or back office. So where do you think you stand in that kind of process? Do you believe you can meaningfully manage, as you expand, or reduce costs on the fly?

Roy Olivier executive
#16

Josh, would you like to describe what you're doing in the software area?

Josh Nicholson executive
#17

Yeah, so on the product side, we're going all in on the most cutting-edge AI, working hand in hand with the dev team — that means AI for building software, AI for code review, plus software that checks accessibility on its own. I've likely turned into a pest around the office simply because I push it so hard. And I'd say the effect on deployment, and on how fast we're getting things done, is quite striking. That's genuinely changed how I see things, and I believe it feeds into our strategy too, since we understand how capable these AI tools are and how we can fit into this landscape in a sharply defined manner, with our advantages put to use. So I think it's making everybody — not only those of us in product; I've run plenty of internal training sessions, including one today — but the whole team far more productive, far more efficient, and it can genuinely stretch from product development into stronger engagement with publishers, stronger engagement with customers. And I'd add that although I'm genuinely thrilled about it and we've come a long way, there's still work ahead; so I see a large and thrilling opportunity there, simply because it has reshaped how I work personally, how our team works, and I think that's beginning to spread across the entire company, which is truly excellent.

Dave Kutil executive
#18

What I'd add is that having the proper tools matters a great deal, and that is precisely what Josh has pinpointed inside the company — possessing the proper tools so that our team can generate the analysis on the back end of the business, the kind that truly puts priority on the areas where time and money can be saved. And we are still in the early stages of this. As Josh mentioned, he is running training this week, yet it is growing quickly; and the incredible part is that the use cases show up right away. And the savings in time and money become visible immediately. So early stages, but we certainly — the proper tools are available to us at this moment.

Roy Olivier executive
#19

Right. I’d just like to say that, for us, AI up to now has truly acted as a multiplier of productivity. It isn’t a product meant for cutting costs. It’s being applied a great deal in development. Josh has been teaching staff in-house how to work with the new QA tool set to build advanced reports that in the past we hired an outside data scientist to produce. And actually, a project discussed during today’s meeting about pinpointing the exact dollars tied to this B2C2B flow that we mention from a sales angle, we will handle all of that through AI using essentially quad tools; yet, looking at the other side, the roughly 60 people we have connected to the DocDel business perform tasks that are difficult to substitute with AI; so there could be a modest chance for savings there; but the bulk of what we’ve observed from AI thus far has been a dramatic boost in productivity among highly compensated softwaregers, FD&A personnel, data analysts, and so on, rather than necessarily a reduction in cost at this stage.

Richard Baldry analyst
#20

Then, finally, from my side. When you consider the point at which you move up into what you might call infrastructure and the ASP becomes substantially greater, could you describe just how big that market opportunity is — or how many verticals it might reach — to give us a sense of where that could carry you across the coming few years should that momentum keep building?

Roy Olivier executive
#21

Well, I believe the vertical markets we serve remain the same, and our TAM is comparable to what it was previously. The ASP could be 20%, 30% above where it stands today, I think. That said, honestly, we will need to investigate and build out certain new pricing models, given how differently these products function. Regarding the MCP product and AI, we touched briefly on the fact that this is genuinely analysis of a volume of calls rather than analysis of users per week per month; historically, then, our focus has always been on the count of users engaging with the product. Going forward, certain customers of ours who have adopted this technology are handling 200,000 calls each month, nearing 300,000 calls each month. And that will call for a different pricing model, along with a different way of sharing that model with the publishers to reflect their contact with the MCP. This will need to be developed and likely refined across the next 12 months; so I don't believe we yet have a complete grasp of the pricing dimension. What we do know is that it will represent a lift over where we stand today, or at least we believe it will. And honestly, we're enthusiastic about this shift, since user seat licensing looks very different from the enormous usage generated by these AI engines and by people posing questions to them. Josh, is there anything you'd like to add?

Josh Nicholson executive
#22

Yeah. When it comes to the sales cycle and how we go to market, the trial essentially involves a technical buyer, and possibly a few executives, who are evaluating it. From what we hear anecdotally, it tends to be quicker: you give them a week, they try it, it does the job, it gets integrated, and then potentially thousands of individuals end up using it. That's not the same as, say, "We'll bring in 30 people. We'll run training sessions. We'll do those sessions again." Perhaps a single guy isn't a fan, perhaps a single person is a fan, and so on. So I'd argue selling is much more simple. It's far more repeatable. It's also much clearer regarding what we're delivering. And then once more, if you embed it into whatever they've already put money into internally, at times in certain of those rival products, it genuinely expands; so I believe it's giving us focus, and I think that's positive. And yes, our tiered structure for API calls will likely change over time. We do increase it as usage grows. So that's another good aspect, since the more it gets used, the more it grows per call; so I'm quite enthusiastic about that.

Derek Greenberg analyst
#23

First, I'd like to discuss the transaction segment. You mentioned expecting additional decreases during the back half. Is that measured against the same period last year, or is it quarter-over-quarter from where we stand now? Also, in the previous quarter, you noted this stemmed from one big account churning plus reduced spending by other major clients. Have any further accounts churned or pulled back, or do these decreases mostly trace back to that same group of customers you referenced before?

Roy Olivier executive
#24

Yeah, when it comes to the transactional side, it's mainly a single sizable customer churning, and we anticipate that continuing. Our DocDel volume tends to be higher in the back half than the front half. Looking ahead, we anticipate doing more in the back half than what was done during the front half of this year. That said, we still anticipate reporting a decrease versus the same period last year stemming from the churn. I believe I said at some point, or perhaps it was cut from an earlier draft, that excluding the churning customer, transactional revenue declined roughly 2% versus the prior year; that falls inside what we'd view as typical seasonality and usage patterns for that business. Occasionally we get an unexplained drop tied to research intensity. Other times there's an unexplained rise because someone else kicked off a research spike in a certain area. We examine those 1,300-plus customers purchasing DocDel from us — really the top 10, top 20 — and again, excluding the churn, those are the ones generating most of that variability; for instance, a couple of our largest customers purchased less this year compared with last year. So we reach out to them. Actually, one is so large that I phone them myself, since I handle that relationship, and I ask, why are you folks down? And the response is, "I don't know. I suppose we're simply conducting less research." So at times the customer themselves can't explain why they might be up or down versus the prior year; regardless, we do anticipate the back half being stronger; we do anticipate continuing to report a decrease versus last year due to the churning customer. And we'll observe what occurs with that typical seasonality, where we swing between a small loss and a small gain; we'll see how that plays out.

Derek Greenberg analyst
#25

Moving on to the API side of things, I'd like to know whether you perceive a possible risk in, for instance, LLM companies striking licensing deals for content comparable to yours, or whether you're mostly protected from that and actually gain from possessing that long tail of research. Could you expand on this a bit more?

Roy Olivier executive
#26

To put it plainly, you should view the API business as either an API or what people call an MCP — essentially a connector into an LLM. So either the client built their own set of tools in-house and they're tapping our API, or we're linked to an LLM where you're essentially posing queries to Claude that is communicating with site to deliver a superior response compared to what it would pull from the open Internet. After you receive the fully sided answer, you can once more ask Claude to fetch the articles for you, and we'll verify your entitlements, we'll verify your rights. We'll retrieve those articles for you. Not only will we send them to you wherever you happen to be, but we'll place them into your corporate library so you hold official "ownership of those" and they sit within your company library. So when we discuss API, the API and MCP operate in a very, very comparable way. The only difference is one serves clients who developed tools internally, while the other is designed specifically to interact with an LLM. Regarding your second question about whether the LLMs will replicate that capability — none of them currently do. Eventually they will begin replicating part of that capability, or a publisher will build its own MCP to link to an LLM. For instance, if you take the top 5 publishers, they will likely each build their own MCP that you can hook to an LLM, which will give you a superior answer than plain abstract data, though not the complete article. As that unfolds, where we'll compete is in the long tail of medium and small publishers lacking the capability or the means to build their own MCP, first of all; and second, nobody wants 200 connectors plugged into their LLM, just as our biggest clients don't want to negotiate 200 agreements with 200 publishers. So they might sign direct agreements with the top 5 publishers, while we cover the gap for the next 100 or 150 publishers. I believe the same dynamic will unfold in that MCP space, essentially the AI space. Josh, is there anything you'd like to add?

Josh Nicholson executive
#27

Yeah, and to make sure it's clear, we have two endpoints in this. The first is the calling site, where the goal is getting an answer, and after that you call Article Galaxy for access. So once again, the majority of our platform customers on Article Galaxy aren't using the API right now. Our API had gotten somewhat outdated; we've updated it. We've brought it back out, and we're beginning to promote it internally now. But I believe going where there are enormous numbers of users will drive usage across both of those. Roy mentioned this, but to build on it further, we're also collaborating with publishers and telling them, "Look, we already hold your content, we have the infrastructure. We're able to take care of authentication ourselves. Same goes for monitoring how much something gets used. So this whole idea of AI consuming articles—that's an entirely new thing. We have the ability to sell articles for you. You can turn on entitlements via subscriptions, via tokens, through all sorts of different methods. And we can pull this off really smoothly across these various chatbots—again, Claude, internal Claude, ChatGPT, and so forth. That's why we're in ongoing conversations with publishers, trying to guide them through this. Unless they're lucky enough to be among the big 5, they just don't have the resources to build something like this on their own. So our role here is that of an infrastructure partner. There are potentially some intriguing new ways to bring in revenue that this could open up — perhaps a portion of subscription fees, or some kind of separate charge. I see two distinct layers here. First, we look at how we can better serve the publishers we already work with. Then, we consider how to expand those offerings so that virtually anybody could use them — including the general public accessing LLMs. So that progress has me enthusiastic, and once again I believe we're in a strong spot thanks to our relationships and our technology — plus that technology delivers value to both products. One more thing worth noting: a particular assay caught my attention. The idea of doing away with the "PDF" has been a topic of conversation for quite a while. I believe the PDF remains available, though what struck me as notable was his description of the shift toward research objects, correct? Whenever individuals seek answers, they'll require a complete full-text article, particularly due to compliance requirements, yet they're beginning to receive these objects, right? And then those < > statements, the pieces we possess, function as research objects in numerous respects. So once again, I'm genuinely enthusiastic about essentially where we stand, and I believe that's being validated internally through the B2B side, plus there's considerably more opportunity ahead. Beyond that, we've brought in some fresh clients from beyond the sector — places like banks, hedge funds and investment banks — who are tapping APIs to support their own research work.

George Melas analyst
#28

I believe the earlier responses mostly addressed what I asked, though perhaps I could probe a bit further, and I'm not sure whether you're able to respond, but what's your outlook on how things will evolve with that long tail of publishers — meaning those beyond the top 5 — and with how many of them have you had some kind of conversation regarding implementing this DocDel? Also, what's their response? How — what's your sense of how that will unfold? And what obstacles stand in the way of delivering that new functionality and that new service that would be mutually beneficial for them and for you?

Roy Olivier executive
#29

Let me just lay a bit of groundwork. What I mean is that long tail has been where we've excelled for 10 years, correct? I mean our bigger customers — the biggest ones we have, they work out rights directly for everyone else, and then usually we come in with that long tail. And Josh, I'll hand it to you to discuss how we're doing in our conversations with the long tail regarding AI rights, DMCP, and so on.

Josh Nicholson executive
#30

Yeah. I mean, when you consider the way distribution works now, publishers are really feeling that pain, correct? Their subscription models are under pressure; they're asking themselves, what's our move here? Their material is being consumed by AI systems, and so on. That said, we definitely occupy a strong position with these publishers, though I believe we're also beginning to establish ties with new ones we hadn't previously engaged with. A few of the bigger players, where I sense there's room for collaboration, plus some smaller ones who might have been waiting for a different reason. So I've had a whole series of conversations with publishers of varying sizes focused on exactly this issue. More are scheduled. What strikes me as notable is that, first, we don't play favorites among publishers; second, we've already completed much of the work processing their articles. That means they face zero initial expense; the development is already underway on our side. We demonstrate to them, "Look, this is how you can track usage. If you'd like to enable it for a particular customer, that's something we take care of. If you want it activated in a particular manner via Access Justice Journal, that's also something we take care of." So there's been genuine demand, I'd say, thanks to that enduring connection we share. And also because I believe it speeds up the other side of that business, where it isn't solely about generating AI reads, which assists them in proving their product's worth, but ultimately also fuels DocDel. Since when you get right down to it, individuals will continue to require the full text, or the AI will need full text to operate using those chunks. So I'd call it a solid progression, and my hope is that it keeps progressing, since I believe it makes us stronger in this changing landscape.

George Melas analyst
#31

At this point, are you seeing any effect on revenue right now? Or is it simply too minor to make a meaningful difference?

Roy Olivier executive
#32

I'd say it remains fairly limited, though we are beginning to gain some momentum in that area.

Josh Nicholson executive
#33

Yeah, and I believe that's a piece of this riddle, correct? Someone might want to use AI with an article in a few different manners, right? There's RightFind, which we discussed before, and that provides AI rights at the level of a single article, but folks also want AI rights covering a set of articles — for hundreds of articles or for thousands of articles, right? And I think this MCP and this effort we're undertaking alongside publishers truly signals, hey, you can sell a subscription and you can sell a subscription that has AI layered on top of it; we serve as the infrastructure for that — the authentication, the tracking, the usage of that, et cetera. And I think that assists publishers enormously since they're dealing with budgetary pressure and the usage isn't merely DocDel falling off, but subscription falling off as people read less, right, because of this zero-click phenomenon. And so I think it's too early to sort of say, but I think we're positioned well; and we do see these big publishers making big announcements with MCPs, but I think we have a somewhat differentiated moat with our citation graph, the DocDel and RightFind side of it and the fact that we aren't a large publisher that might be off putting for a smaller publisher to work with.

George Melas analyst
#34

With these new clients, plus the strong track record you've built bringing B2B customers on board — are they really leaning into it? Is there a fresh pattern emerging?

Josh Nicholson executive
#35

Yeah. Once more, there's a minimum on our API pricing that's already much larger than what our typical contract costs, and that's only the minimum; so again, part of this simply wasn't where we were aimed before. A great deal of our effort has gone toward figuring this out. And as Roy pointed out, certain of those business models will change over time, yet it's very heartening, since I personally handle many of these API deals because there's a technical dimension involved. Still, in some respects it's actually simpler, given that testing is easier. You basically witness the gains immediately. After that, the worth is fairly clear, correct? If you'd rather devote 10 years to speaking with each and every publisher, go right ahead. If you'd rather team up with us, obtain access to patents, obtain access to research articles, be given the option to purchase or rent an article, all in a single spot, that's a lot simpler. So that demand exists. And once more, the bigger invoices being sent out show it.

Roy Olivier executive
#36

Well, I appreciate all of you being here today. Just a quick note, on March 23 we'll be taking part in the ROTH Capital Partners Conference out in Dana Point, California. Hope to talk with you at that point. Thanks.

Roy Olivier executive
#37

Thank you.

Operator operator
#38

Thanks.

Read the full transcript via the API

You're viewing the first half of this call. Get the complete Research Solutions, Inc. transcript - plus 131,000+ transcripts from 7,000+ companies, speaker segments and full-text search - through the EarningsAPI REST API or hosted MCP server.

Get an API key View API docs →

For developers and AI pipelines

Programmatic access to Research Solutions, Inc. earnings transcripts and 131,000+ others is available through the EarningsAPI REST API and the hosted MCP server. Quarterly plans from $162 - full transcripts, speaker segments, full-text search, and the /api/v1/transcripts/recent polling endpoint for ETL pipelines.